Anticoagulants in heart disease: current status and perspectives.
De Caterina
Raffaele
R
Institute of Cardiology, G. d'Annunzio University - Chieti, Ospedale S. Camillo de Lellis, Chieti, Italy. rdecater@unich.it
Husted
Steen
S
Wallentin
Lars
L
Agnelli
Giancarlo
G
Bachmann
Fedor
F
Baigent
Colin
C
Jespersen
Jørgen
J
Kristensen
Steen Dalby
SD
Montalescot
Gilles
G
Siegbahn
Agneta
A
Verheugt
Freek W A
FW
Weitz
Jeffrey
J
D000284:Administration, Oral; D000925:Anticoagulants / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000188:drug therapy*; D000075202:Contraindications; D004338:Drug Combinations; D065427:Factor Xa Inhibitors; D005544:Forecasting; D006331:Heart Diseases / Q000188:drug therapy*; D006470:Hemorrhage / Q000139:chemically induced; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D007263:Infusions, Parenteral; D019095:Point-of-Care Systems; D012307:Risk Factors; D013917:Thrombin / Q000037:antagonists & inhibitors; D014812:Vitamin K / Q000037:antagonists & inhibitors
D000925:Anticoagulants; D004338:Drug Combinations; D065427:Factor Xa Inhibitors; D014812:Vitamin K; D013917:Thrombin